英文名称：N - Formyl - Nle - Leu - Phe - Nle - Tyr - Lys TFA 中文名称：N - 甲酰基 - 正亮氨酸 - 亮氨酸 - 苯丙氨酸 - 正亮氨酸 - 酪氨酸 - 赖氨酸 三氟乙酸盐 氨基酸序列：甲酰基 - 正亮氨酸 - 亮氨酸 - 苯丙氨酸 - 正亮氨酸 - 酪氨酸 - 赖氨酸 单字母序列：f - Nle - Leu - Phe - Nle ...

The effects of RvD1 in promoting IL-10 production were also inhibited by N-formyl peptide receptor 2 (FPR2) antagonist. The primary cultured DRG neurons apoptosis increased after stimulation with ...

National Engineering Research Center for Carbohydrate Synthesis, Jiangxi Province Key Laboratory of Natural and Biomimetic Drugs Research, College of Chemistry and Materials, Jiangxi Normal University ...

在这项研究中，研究人员鉴定出 FPR2（Formyl Peptide Receptor 2）是一种能够特异性结合长链神经酰胺（C14 - C20）的膜受体。在棕色和米色脂肪细胞中，C16:0 神经酰胺与 FPR2 结合，会通过 G i - 环磷酸腺苷（cyclic AMP）信号通路抑制产热（thermogenesis），而在缺乏 FPR2 的 ...

英文名称：FSL - 1 TFA（Formyl - SKLK - amide trifluoroacetate） 中文名称：甲酰化 - SKLK - 酰胺三氟乙酸盐 氨基酸序列：丝氨酸 - 赖氨酸 - 亮氨酸 - 赖氨酸（Ser - Lys - Leu - Lys） 单字母序列：SKLK 三字母序列：Ser - Lys - Leu - Lys 分子量：游离碱形式的 FSL - 1（不考虑 TFA ...

As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists of 2 major phases: (1) initiation (also called apreinflammatory stage) and (2) perpetuation ...

用于治疗 IBD 的促消退或修复药物尚未问世，不过像甲酰肽受体 2（Formyl Peptide Receptor 2，FPR2/ALX）这样的潜在靶点或许能填补这一空白。在这项研究中，研究人员评估了两种小分子 FPR2/ALX 调节剂（激动剂 Quin-C1 和拮抗剂 Quin-C7）对 IBD 的治疗效果。研究人员首先 ...

Detecting danger is key to the survival and success of all species. Animal nervous and immune systems cooperate to optimize danger detection. Preceding studies have highlighted the benefits of ...

School of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in various organs, leading to ...

Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 76100, Israel ...

Alice T. Epitropoulos, MD, FACS, outlines her approach to managing evaporative dry eye. This includes diagnosing meibomian gland dysfunction, using thermal pulsation to clear gland blockages, and ...